Ikarian Capital’s Korro Bio KRRO Stock Holding History

Ikarian Capital’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,398	Closed	-$696K	–	241
2021 Q2	$696K	Buy	1,398 +268	+24%	+$131K	0.06%	174
2021 Q1	$536K	Buy	+1,130	New	+$2.2M	0.02%	255

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's KRRO Position: Q3 2021 in Review

Ikarian Capital sold out of Korro Bio (KRRO) in Q3 2021, closing a stake of 1,398 shares — an estimated $696K sold.

Ikarian Capital first reported a position in KRRO in Q1 2021 and held it in 2 quarters. The position peaked at $696K in Q2 2021. 88 funds tracked by Wall St. Rank hold KRRO as of Q3 2021.

Ikarian Capital reported no remaining Korro Bio position as of Q3 2021 after selling out during the quarter.
Ikarian Capital sold 1,398 Korro Bio shares in Q3 2021, an estimated $696K.
Ikarian Capital first reported a position in Korro Bio in Q1 2021 and held it in 2 quarters.
Ikarian Capital's Korro Bio position peaked at $696K in Q2 2021.
88 funds tracked by Wall St. Rank held Korro Bio as of Q3 2021.

Based on Ikarian Capital's 13F filing for Q3 2021, filed 15 Nov 2021.